Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Hain Celestial (HAIN) To Hire New CEO, Reiterates '18 View

Published 06/25/2018, 10:39 PM
Updated 07/09/2023, 06:31 AM

The Hain Celestial Group, Inc. (NASDAQ:HAIN) recently announced plans to appoint a new chief executive officer. Meanwhile, Irwin D. Simon, the present founder, president and chief executive officer, will serve as non-executive chairman of the board.

Concurrent with the announcement, management reiterated fiscal 2018 financial guidance. Notably, Hain Celestial continues to expect earnings per share in the range of $1.11-$1.18 and net sales between $2.43 billion and $2.50 billion. The company is also progressing with plans to divest Hain Pure Protein Corporation in the first half of fiscal 2019. This divestment is likely to boost efficiency and simplify brand portfolio.

Apart from this, Hain Celestial is undertaking several other initiatives to boost the top line, which missed expectations in the third quarter. The company initiated a strategic review under Project Terra in fiscal 2016 and expects to generate worldwide cost savings worth $350 million through fiscal 2020 (comprising annual productivity).

However, the company continues to witness increase in SG&A expenses. Notably, SG&A expenses for the third quarter rose 13%. As a percentage of sales, the same increased 50 basis points (bps) to 13.4%. In the second and first quarter, SG&A expenses increased 6.1% and 6.8%, respectively. This led to the contraction of operating margin by 110 bps.

Further, this Zacks Rank #5 (Strong Sell) stock faces strong competition in the natural and organic foods market and the personal care products segment. This may compel the company to embrace aggressive pricing and promotional strategies which may further dent margins and hurt the top line. Apart from these, currency fluctuation is another headwind.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Consequently, Hain Celestial’s shares have lost 6.5% in the last three months, against the industry’s rise of 4% and the overall sector’s decline of 2.7%.

3 Stocks Hogging the Limelight

Medifast, Inc (NYSE:MED) has a long-term earnings growth rate of 15% and sports a Zacks rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

B&G Foods, Inc (NYSE:BGS) delivered an average positive earnings surprise of 0.7% in the trailing four quarters and carries a Zacks Rank #2 (Buy).

The Chefs' Warehouse, Inc (NASDAQ:CHEF) has a long-term earnings growth rate of 22% and carries a Zacks Rank #2.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>



The Hain Celestial Group, Inc. (HAIN): Free Stock Analysis Report

B&G Foods, Inc. (BGS): Get Free Report

The Chefs' Warehouse, Inc. (CHEF): Free Stock Analysis Report

MEDIFAST INC (MED): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.